Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Liebman

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline updateGary H Lyman, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014Gary H Lyman, Kari Bohlke, Alok A Khorana, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Blood|March 16, 2025
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 studyDavid J Kuter, Waleed Ghanima, Nichola Cooper, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline updateGary H Lyman, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014Gary H Lyman, Kari Bohlke, Alok A Khorana, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Blood|March 16, 2025
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 studyDavid J Kuter, Waleed Ghanima, Nichola Cooper, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Pageof 7